Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.20.2
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Summary of Significant Accounting Policies (Textual)            
Goodwill impairment charge $ 0 $ 9,000,000.0 $ 0 $ 8,996,000 $ 0  
Revenue recognized     $ 0 7,912,000 $ 0  
VAT payable 7,591,000     7,591,000   $ 0
Value added tax receivable 4,500,000     4,500,000    
Business combination, indemnification asset 900,000     900,000    
VAT expense, net 2,200,000          
Bill-And-Hold            
Summary of Significant Accounting Policies (Textual)            
Revenue recognized $ 500,000     1,500,000    
United States            
Summary of Significant Accounting Policies (Textual)            
Goodwill impairment charge       $ 8,996,000    
Accounts Receivable | Customer Concentration Risk            
Summary of Significant Accounting Policies (Textual)            
Concentration risk, percentage       10.70%    
Services | Revenue Benchmark | Product Concentration Risk            
Summary of Significant Accounting Policies (Textual)            
Concentration risk, percentage 0.10%   0.10% 0.10% 0.10%  
Mint Products | Revenue Benchmark | Product Concentration Risk            
Summary of Significant Accounting Policies (Textual)            
Concentration risk, percentage 0.10%   19.70% 0.10% 17.20%  
Products Without PMTA | Revenue Benchmark | Product Concentration Risk            
Summary of Significant Accounting Policies (Textual)            
Concentration risk, percentage       0.40% 0.80%  
Airgraft Inc. | IPO            
Summary of Significant Accounting Policies (Textual)            
Liability for returns included in accrued expenses $ 700,000     $ 700,000   600,000
Other current assets $ 200,000     $ 200,000   $ 300,000